Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AP Inspector Training Slowed By Weak Industry Support, Restrictive FDA Policies

This article was originally published in The Silver Sheet

Executive Summary

FDA’s THIRD-PARTY INSPECTION PROGRAM, which will allow device manufacturers to hire agency-approved "accredited persons" (APs) to perform FDA quality systems inspections, is progressing slowly as APs continue to undergo training. A dearth of device firms volunteering to host qualifying audits is largely to blame, FDA says, but the agency’s approach to managing the training process also appears to be causing delays. The National Electrical Manufacturers Association urges members to step forward for joint FDA/AP training audits, viewing the new program as a crucial means of advancing worldwide acceptance of the concept of third-party inspections

You may also be interested in...



FDA Considers Using Third-Party Inspectors to Enhance Global Reach

FDA is talking about adding an outsourced inspectorate to help it police the globally outsourced pharmaceutical manufacturing industry.

Second EU MDR Notified Body Designated In France

Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036090

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel